PTC Therapeutics to Collaborate With Roche

PTC Therapeutics, Inc. announced an exclusive research collaboration and licensing agreement with Roche for the development of orally bioavailable small molecules utilizing PTC’s technology called Gene Expression Modulation by Small-molecules.
News Blaze